Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Heparan sulfate proteoglycans (HSPG s) have essential functions during embryonic development and throughout postnatal life. To exert these functions, they undergo a series of processing reactions by heparan‐sulfate‐modifying enzymes (HSME s), which endows them with highly modified heparan sulfate (HS) domains that provide specific docking sites for a large number of bioactive molecules. The development and antigen‐dependent differentiation of normal B lymphocytes, as well as the growth and progression of B‐lineage malignancies, are orchestrated by an array of growth factors, cytokines and chemokines many of which display HS binding. As discussed in this review, tightly regulated HSPG expression is a requirement for normal B cell maturation, differentiation and function. In addition, the HSPG syndecan‐1 functions as a versatile co‐receptor for signals from the bone marrow microenvironment, essential for the survival of long‐lived plasma cells and multiple myeloma (MM) plasma cells. Targeting of HSME s or HS chains on MM cells increases their sensitivity to drugs currently used in MM treatment, including bortezomib, lenalidomide or dexamethasone. Taken together, these findings render the HS biosynthetic machinery a promising target for MM treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heparan sulphate proteoglycans fine-tune mammalian physiology
Bishop, J. R., Schuksz, M., & Esko, J. D. (2007) · Nature · doi:10.1038/nature05817 · Cited by 1,631
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932
Moreaux, J., Legouffe, E., Jourdan, E., Quittet, P., Rème, T., Lugagne, C., Moine, P., Rossi, J.-F., Klein, B., & Tarte, K. (2004) · Blood · doi:10.1182/blood-2003-06-1984 · Cited by 558
Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals
Cassese, G., Arce, S., Hauser, A. E., Lehnert, K., Moewes, B., Mostarac, M., Muehlinghaus, G., Szyska, M., Radbruch, A., & Manz, R. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1684 · Cited by 487
Disruption of Gastrulation and Heparan Sulfate Biosynthesis in EXT1-Deficient Mice
Lin, X., Wei, G., Shi, Z., Dryer, L., Esko, J. D., Wells, D. E., & Matzuk, M. M. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9798 · Cited by 427
Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans
Yoneda, A., & Couchman, J. R. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00010-6 · Cited by 174
Mahtouk, K., Cremer, F. W., Rème, T., Jourdan, M., Baudard, M., Moreaux, J., Requirand, G., Fiol, G., De Vos, J., Moos, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209699 · Cited by 105
Cited by
Tai, Y.-T., Acharya, C., An, G., Moschetta, M., Zhong, M. Y., Feng, X., Cea, M., Cagnetta, A., Wen, K., van Eenennaam, H., et al. (2016) · Blood · doi:10.1182/blood-2016-01-691162 · Cited by 350
The maintenance of memory plasma cells
Khodadadi, L., Cheng, Q., Radbruch, A., & Hiepe, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00721 · Cited by 232
“Some investigators doubt that CD138 is important for plasma cell function under normal conditions (72), but recent evidence shows that CD138 plays a direct cell-intrinsic role in plasma cell survival in vivo (73).”
BackgroundAberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
van Andel, H., Kocemba, K. A., Spaargaren, M., & Pals, S. T. (2019) · Leukemia · doi:10.1038/s41375-019-0404-1 · Cited by 188
Self-citationThe Glycome of Normal and Malignant Plasma Cells
Moehler, T. M., Seckinger, A., Hose, D., Andrulis, M., Moreaux, J., Hielscher, T., Willhauck-Fleckenstein, M., Merling, A., Bertsch, U., Jauch, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083719 · Cited by 17
“The relevance of regulated enzymatic activity for proteoheparansulfate synthesis has been demonstrated by knockdown of EXT1 also involved in the chain elongation of heparan sulfate chains [23,53] leading to reduced growth and increased apoptosis in myeloma cells.”
Background
Metadata
- Authors
- Reijmers, R. M., Spaargaren, M., & Pals, S. T.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2013-03-04
- Volume
- 280
- Issue
- 10
- Pages
- 2180-2193
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2018644412
- Cited by
- 55
- References
- 8
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma. https://app.cochat.ai/papers/10.1111/febs.12180
- The paper
- Reijmers, R. M., Spaargaren, M., & Pals, S. T. (2013). Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma. The FEBS Journal. https://doi.org/10.1111/febs.12180
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.